Survodutide for the treatment of obesity: baseline characteristics of the SYNCHRONIZE cardiovascular outcomes trial : brief report
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Langue: | anglais |
| Publié: |
May 2026
|
| In: |
JACC Heart failure
Year: 2026, Volume: 14, Numéro: 5, Pages: 1-5 |
| ISSN: | 2213-1787 |
| DOI: | 10.1016/j.jchf.2025.102780 |
| Accès en ligne: | Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.jchf.2025.102780 Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S2213177925007103 |
| Notes sur l'auteur: | Elke Platz, MD, MS, Lee M. Kaplan, MD, PHD, Carel W. le Roux, MD, PHD, Sean Wharton, MD, Svenja Burger, PHD, Samina Ajaz Hussain, MD, Martina Brueckmann, MD, Elena Startseva, MD, MBA, Constanze Fey, PHD, Mikhail N. Kosiborod, MD, Biykem Bozkurt, MD, PHD |
| Description: | Online verfügbar: 3. November 2025, Artikelversion: 4. Mai 2026 Gesehen am 09.07.2026 |
|---|---|
| Description matérielle: | Online Resource |
| ISSN: | 2213-1787 |
| DOI: | 10.1016/j.jchf.2025.102780 |